Imperial College Hammersmith Campus
London, W12 0NN, United Kingdom
NCT Number: NCT00230672
Hereditary Haemorrhagic Telangiectasia (HHT, also known as Osler-Weber-Rendu Syndrome) is an disease that leads to the development of dilated and fragile blood vessels, including arteriovenous malformations in the lungs (PAVMs). We hypothesize that the genetically-determined abnormality in the blood vessels of HHT patients leads to alteration in the concentrations or activity of several proteins in the blood stream. We propose to take blood samples from patients at defined times in order to study changes in blood protein levels and activity
Looking for future studies?
Notify MeAll sexes
Observational
London, W12 0NN, United Kingdom
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Patients with hereditary haemorrhagic telangiectasia and pulmonary arteriovenous malformations -
Exclusion criteria
Unable to provide informed consent
-
Imperial College London
Other
Studies of Plasma Proteins Derived From Pulmonary Arteriovenous Malformation Patients
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02157987
Cardiovascular Abnormalities, Cardiovascular Diseases
Caen, France
View Trial DetailsNCT04108052
Arteriovenous Malformations, Cardiovascular Abnormalities
Bron, France
View Trial DetailsNCT02484716
Cardiovascular Abnormalities, Cardiovascular Diseases
Bron, France
View Trial DetailsNCT03227263
Cardiovascular Abnormalities, Cardiovascular Diseases
Angers, France
View Trial Details